Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What Growth Rate is the Biomarkers Market Anticipated to Experience from 2025-2034?
In recent times, the biomarkers market has seen significant growth. The market value is projected to increase from $68.77 billion in 2024 to $78.14 billion in 2025, showcasing a compound annual growth rate (CAGR) of 13.6%. The surge in growth during the historical period can be attributed to factors such as the progression of genomics and proteomics technologies, a higher incidence of chronic diseases, a growing focus on personalized medicine, an increased need for companion diagnostics, and the broadening of applications in drug development.
In the coming years, the biomarkers market size is set for fast-paced expansion. It is slated to grow to $135.14 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. The factors driving the growth during the forecast period include increasing emphasis on early disease detection and prevention, widening usage of biomarkers in oncology and immunotherapy, escalating investment in precision medicine initiatives, popularity of liquid biopsy as a non-invasive method for biomarker detection, and a growing preference for biomarkers in the field of drug discovery and development. Key trends forecasted for the period encompass the development of multi-biomarker panels, the rise of exosome-based biomarkers, the adoption of point-of-care biomarker testing, the integration of real-world data into biomarker research, and the exploration of microbiome-based biomarkers.
Claim Your Free Sample of the Global Biomarkers Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=6485&type=smp
What Are the Major Factors Contributing to the biomarkers Market Expansion?
The rise in cardiac conditions is anticipated to fuel the expansion of the biomarkers market during the projected period. The application of biomarkers in treating heart disease patients has vastly grown in recent years. Presently, biomarkers like natriuretic peptides, being most favored, are used to diagnose patients suffering from heart failure. Cardiac ailments are one of the prime causes of mortality across various racial and ethnic groups in the US, thereby driving the demand for biomarkers. For instance, a report published by the American College of Cardiology, a US-based medical non-profit organization in August 2022, predicted that all four cardiovascular risk factors are projected to elevate between 2025 and 2060. Diabetes is expected to see the highest percentage growth of 39.3%, amounting to 55 million individuals, followed by dyslipidemia (27.6% equating to 126 million), hypertension (25.1% coming to 162 million), and obesity (18.3% totaling 126 million). The examination also pointed out considerable projected increases in stroke rates (33.8% equalling 15 million) and heart failures (33.4% amounting to 13 million), after which is ischemic heart disease (30.7% equally 29 million) and heart attack (16.9% coming to 16 million). Due to the surge in heart ailments and resultant deaths, the biomarkers market is set for significant growth.
Which Key Segments Shape the Biomarkers Market?
The biomarkers market covered in this report is segmented – _x000D_
_x000D_
1) By Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers_x000D_
2) By Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases_x000D_
3) By Type: Biomarker Of Exposure, Biomarker Of Diseases_x000D_
4) By Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies_x000D_
_x000D_
Subsegments:_x000D_
1) By Safety Biomarkers: Toxicity Biomarkers, Pharmacokinetic Biomarkers, Adverse Effect Biomarkers _x000D_
2) By Efficacy Biomarkers: Pharmacodynamic Biomarkers, Disease Progression Biomarkers, Treatment Response Biomarkers_x000D_
3) By Validation Biomarkers: Analytical Validation Biomarkers, Clinical Validation Biomarkers, Qualification Biomarkers_x000D_
What Are the Transformative Trends Influencing the Biomarkers Market?
Leading firms in the biomarker market are concentrating their efforts on the creation of novel solutions such as innovative biological markers. This is achieved through a combination of partnership research, technology amalgamation, and rigorous clinical verification. A novel biological marker refers to a newly discovered sign that indicates biological changes, useful in disease diagnosis or supervision. It could be a certain molecule, gene, or cellular attribute, holding significant potential for personalized medicine. For instance, in September 2024, Genialis, an American company specializing in computational precision medicine, premiered a first-in-class biomarker. This biomarker manages to increase the predictive accuracy of patient responses to KRAS inhibitors. This facilitates individualized treatment plans and betters clinical results, with its far-reaching application across various cancer species furthering efficient drug creation and fine-tuning patient selection for specialized therapies.
Order Now for Fast Delivery of Your Biomarkers Market Report!
https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report
What Regions Are Leading the Growth Trajectory of the Biomarkers Market?
North America was the largest region in the biomarkers market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Biomarkers Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the biomarkers market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Biomarkers Market Include
1. Biomarkers Market Executive Summary
2. Biomarkers Market Segments
3. Biomarkers Market Size And Template Market Growth Rate
4. Key Biomarkers Market Trends
5. Major Biomarkers Market Drivers
……
25. Key Mergers And Acquisitions In The Biomarkers Market
26. Top Biomarkers Companies
27. Biomarkers Market Opportunities And Strategies
28. Biomarkers Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Biologics Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery
https://www.thebusinessresearchcompany.com/report/biologics-market
Acne Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report
Dermatitis Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
